Emiko Sugiyama

Pharmacokinetics of Gemcitabine in Japanese Cancer Patients: The Impact of a Cytidine Deaminase Polymorphism

Emiko Sugiyama, Nahoko Kaniwa, Su-Ryang Kim et al. · Journal of Clinical Oncology · 2006 · 187 citations

Medicine, Oncology, Pharmacology +16

A whole-genome association study of major determinants for allopurinol-related Stevens–Johnson syndrome and toxic epidermal necrolysis in Japanese patients

Masahiro Tohkin, Nahoko Kaniwa, Yoshiro Saito et al. · The Pharmacogenomics Journal · 2011 · 186 citations

Life Sciences, Molecular Genetics, Molecular Medicine +6

Independent strong association of HLA-A*02:06 and HLA-B*44:03 with cold medicine-related Stevens-Johnson syndrome with severe mucosal involvement

Mayumi Ueta, Nahoko Kaniwa, Chie Sotozono et al. · Scientific Reports · 2014 · 100 citations · Full text

Medicine, Dermatology, Immunology +17

Severe Drug Toxicity Associated with a Single-Nucleotide Polymorphism of the <i>Cytidine Deaminase</i> Gene in a Japanese Cancer Patient Treated with Gemcitabine plus Cisplatin

Kan Yonemori, Hideki Ueno, Takuji Okusaka et al. · Clinical Cancer Research · 2005 · 84 citations · Full text

Medicine, Oncology, Pharmacokinetics +16

Specific HLA Types are Associated with Antiepileptic Drug-Induced Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis in Japanese Subjects

Nahoko Kaniwa, Emiko Sugiyama, Yoshiro Saito et al. · Pharmacogenomics · 2013 · 71 citations

Medicine, Pharmacology, Hypersensitivity +12